Acute oxalate nephropathy: A new etiology for acute renal failure following nonrenal solid organ transplantation

American Journal of Transplantation

Volumn 6, Issue 10, 2006, Pages 2516-2521

  Lefaucheur, C ^a,b   Hill, G S ^b   Amrein, C ^b   Haymann, J P ^c   Jacquot, C ^a,b   Glotz, D ^d   Nochy, D ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c HÔPITAL TENON   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

Acute renal failure; Oxalate nephropathy

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GENTAMICIN; IMIPENEM; KREON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOMYCIN; OXALIC ACID; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; STEROID; TACROLIMUS; TEICOPLANIN; THYMOCYTE ANTIBODY; VANCOMYCIN; VORICONAZOLE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ARTICLE; CASE REPORT; COLON FLORA; CYSTIC FIBROSIS; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; HYPEROXALURIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; OXALIC ACID NEPHROPATHY; PANCREAS INSUFFICIENCY; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; HEART TRANSPLANTATION; HUMANS; HYPEROXALURIA; KIDNEY FAILURE, ACUTE; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION;

EID: 33748499384     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01485.x     Document Type: Article

References (20)

1. Wyatt CM, Arons RR. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation 2004; 78: 1351-1355.
2. Rocha PN, Rocha AT, Palmer SM, Davis RD, Smith SR. Acute renal failure after lung transplantation: Incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant 2005; 5: 1469-1476.
3. Sanchez EQ, Gonwa TA, Levy MF et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004; 78: 1048-1054.
4. Paramesh AS, Roayaie S, Doan Y et al. Post-liver transplant acute renal failure: Factors predicting development of end-stage renal disease. Clin Transplant 2004; 18: 94-99.
5. Cuvelier C, Goffin E, Cosyns JP, Wauthier M, de Strihou CY. Enteric hyperoxaluria: A hidden cause of early renal graft failure in two successive transplants: Spontaneous late graft recovery. Am J Kidney Dis 2002; 40: E3.
6. Hill P, Karim M, Davies DR, Roberts IS, Winearls CG. Rapidly progressive irreversible renal failure in patients with pancreatic insufficiency. Am J Kidney Dis 2003; 42: 842-845.
7. Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: Application of a new test with [13C2]oxalate. J Am Soc Nephrol 1999; 10 (Suppl 14): S329-333.
8. Sidhu H, Hoppe B, Hesse A et al. Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria. Lancet 1998; 352: 1026-1029.
9. Sidhu H, Schmidt ME, Cornelius JG et al. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: Possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 1999; 10 (Suppl 14): S334-S340.
10. Cuvelier C, Goffin E, Cosyns JP et al. Acute renal failure due to naftidrofuryl oxalate Praxilene overdose in a kidney transplant recipient. Nephrol Dial Transplant 1995; 10: 1756-1758.
11. Morgan SH, Watts RW. Perspectives in the assessment and management of patients with primary hyperoxaluria type I. Adv Nephrol Necker Hosp 1989; 18: 95-106.
12. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001; 59: 270-276.
13. Hoppe B, von Unruh GE, Blank G et al. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinos is in cystic fibrosis. Am J Kidney Dis 2005; 46: 440-445.
14. Kumar R, Ghoshal UC, Singh G, Mittal RD. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: Possible role in renal stone formation. J Gastroenterol Hepatol 2004; 19: 1403-1409.
15. Lieske JC, Goldfarb DS, De Simone C, Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 2005; 68: 1244-1249.
16. Schepers MS, van Ballegooijen ES, Bangma CH, Verkoelen CF. Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells. Kidney Int 2005; 68: 1543-1553.
17. Asselman M, Verhulst A, De Broe ME, Verkoelen CF. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 2003; 14: 3155-3166.
18. Khan SR. Crystal-induced inflammation of the kidneys: Results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 2004; 8: 75-88.
19. Verani R, Nasir M, Foley R. Granulomatous interstitial nephritis after a jejunoileal bypass: An ultrastructural and histochemical study. Am J Nephrol 1989; 9: 51-55.
20. Schepers MS, Duim RA, Asselman M, Romijn JC, Schroder FH, Verkoelen CF. Internalization of calcium oxalate crystals by renal tubular cells: A nephron segment-specific process? Kidney Int 2003; 64: 493-500.